Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Price To Sales Ratio

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.

The item "Price-To-Sales-Ratio" stands at 1.41 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Price To Sales Ratio" stands at 1.41. This represents an increase of 48.56 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 95.62 percent compared to the value the year prior.
The 1 year change in percent is 95.62.
The 3 year change in percent is 104.30.

The Serie's long term average value is 0.709. It's latest available value, on 09/30/2025, is 99.11 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +186.41%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Sales Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Sales Ratio486,508,953,600.00
LogoAbbVie Inc - Price To Sales Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Sales Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Sales Ratio280,205,508,085.11